STR16 Antibody

Shipped with Ice Packs
In Stock

Description

Molecular Structure and Target Protein

Syntaxin 16 is a type IV transmembrane protein with distinct structural domains:

  • Cytoplasmic syntaxin region (amino acids 74–180): Mediates SNARE complex interactions.

  • Coiled-coil domain (aa 230–292): Facilitates protein-protein interactions during vesicle docking.

  • Short lumenal C-terminus: Anchors the protein to Golgi membranes .

Multiple isoforms exist due to alternate start sites (e.g., Met187, Met54) and deletions (e.g., aa 45–48, 28–48) . The antibody typically targets epitopes within the cytoplasmic region, such as the immunogen sequence ACSEQEGRLLGNVVASLAQALQELSTSFRHAQSGYLKRMKNREERSQHFFDTSVPLMDDGDDNTLYHR .

DomainFunctionAmino Acid Range
Syntaxin regionSNARE complex formation74–180
Coiled-coil domainProtein oligomerization230–292
Transmembrane anchorGolgi membrane localization323–325

Research Applications

STX16 Antibody is widely used in:

  • Immunohistochemistry (IHC): Mapping STX16 distribution in normal and cancerous tissues .

  • Western Blot (WB): Detecting ~39 kDa bands in lysates from Golgi-rich cell lines .

  • Immunofluorescence (IF): Visualizing STX16 in early endosome-Golgi fusion assays .

Key findings include its 95% amino acid identity with mouse STX16 (aa 165–301), enabling cross-species studies .

Clinical Significance

STX16 Antibody has diagnostic and prognostic implications:

  • Autoimmune Disorders: Elevated titers correlate with myasthenia gravis (MG) and myocarditis, particularly in thymoma-associated cases .

  • Paraneoplastic Syndromes: Titers ≥1:7680 signal higher cancer risk (e.g., adenocarcinoma, sarcoma) .

ConditionAntibody TiterClinical Relevance
Myasthenia GravisAny titerBulbar symptoms, myasthenic crisis
Paraneoplastic Syndromes≥1:7680Oncological risk (e.g., sarcoma)
MyocarditisVariableLethal arrhythmias, heart failure

Validation and Characterization

STX16 Antibodies undergo rigorous validation:

  • Enhanced Protocols: YCharOS uses knockout cell lines for specificity testing in WB and IF .

  • Human Protein Atlas: Includes IHC data across 44 normal and 20 cancer tissues .

  • Protein Arrays: Screened against 364 recombinant human proteins to minimize cross-reactivity .

Validation MethodOutcomeSource
KO Cell Line AssaysConfirmed specificity in 90% of antibodies
Tissue MicroarraysConsistent Golgi-specific staining patterns

Comparative Analysis

While STX16 Antibody focuses on intracellular trafficking, other syntaxin antibodies (e.g., STX1A, STX4) target synaptic vesicle exocytosis or glucose transporters. STX16’s unique role in retrograde transport distinguishes it from syntaxins involved in anterograde pathways .

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
STR16 antibody; At5g66040 antibody; K2A18.11 antibody; Thiosulfate sulfurtransferase 16 antibody; chloroplastic antibody; EC 2.8.1.1 antibody; Rhodanese antibody; Senescence-associated protein antibody; Sulfurtransferase 16 antibody; AtStr16 antibody
Target Names
STR16
Uniprot No.

Target Background

Function
STR16 Antibody is believed to play a role in the early stages of leaf senescence. It catalyzes the transfer of a sulfur ion from a donor to cyanide or other thiol compounds. The enzyme exhibits a preference for thiosulfate over 3-mercaptopyruvate as a substrate.
Database Links

KEGG: ath:AT5G66040

STRING: 3702.AT5G66040.1

UniGene: At.23333

Subcellular Location
Plastid, chloroplast.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.